Form Health Simplifies GLP-1 Coverage Opportunities for Employers with Transparent, Predictable Pricing
Today, Form Health, the national leader in science-based obesity and cardiometabolic care, announced access to new programs that provide employers with transparent, predictable access to obesity management medications from Eli Lilly and Company (Lilly) and Novo Nordisk (Novo), helping organizations offer comprehensive, wraparound care while controlling costs.
Form Health Selected for Novo Nordisk’s NovoCare® Platform to Expand Access to Science-Based Obesity Care Across the United States
Today, Form Health, the leading provider of science-based obesity and cardiometabolic care in the United States, announced its selection as a healthcare provider option on Novo Nordisk’s NovoCare® platform. NovoCare® connects patients seeking treatment for chronic care with trusted healthcare providers, and Form Health’s inclusion will expand access to high-quality, evidence-based care delivered by trained Obesity Medicine Clinicians and Registered Dietitians. The relationship underscores Form Health’s commitment to clinical best practices; comprehensive, personalized treatment plans; and the avoidance of non-FDA approved compounded products that may expose patients to safety risks.
Form Health, the National Leader in Science-Based Total Weight and Cardiometabolic Care, Named a “Fierce 15” Company of 2025
Form Health, the leading provider of science-based total weight and cardiometabolic care in the United States, today announced that Fierce Healthcare has named it as one of 2025’s “Fierce 15” healthcare companies. The annual special report features the most innovative private healthcare companies looking to change the face of the industry.
Form Health, the National Leader in Science-Based Obesity Care, Launches New Program to Prevent Progression from Overweight to Obesity
Today, Form Health, the leading provider of science-based obesity care in the United States, announced a new program to prevent progression from overweight to obesity. Individuals with overweight are at an increased risk of developing obesity and weight-related cardiometabolic conditions like type 2 diabetes, hypertension, hyperlipidemia, and heart disease. Overweight is a treatable medical condition, and Form’s new offering applies a science-based approach to not only prevent obesity and these conditions but also achieve positive outcomes like weight loss and improved health.
Form Health, The Leading Provider of Science-Based Obesity Care in the United States, Raises $38 Million Series B Led By Sound Ventures
Today, Form Health, the leading provider of science-based obesity care in the United States, announced it has raised a $38 million Series B with Sound Ventures serving as the lead investor. M13, SignalFire, and Next View Ventures also participated in the round. Form will use the funds to accelerate its work with enterprise partners, support the hiring of American Board of Obesity Medicine (ABOM) physicians to deliver science-based obesity care, and invest in its telehealth technology platform.
Form Health Modernizes Medical Weight Loss With Virtual Care, Board Certified Physicians, and Medication
Form Health, a pioneer in the emerging field of obesity telemedicine, announced $12M in Series A funding led by M13 with participation from SignalFire and NextView Ventures.
